A PKA/cdc42 Signaling Axis Restricts Angiogenic Sprouting by Regulating Podosome Rosette Biogenesis and Matrix...

Area of Science:

• Molecular Biology
• Cell Biology
• Angiogenesis Research

Background:

• Angiogenic sprouting is crucial in physiological and pathological conditions like ischemic heart disease and cancer.
• While endothelial cell (EC) specification in angiogenesis is understood, the regulation of their distinct actions remains unclear.
• Adrenergic signaling influences angiogenesis, potentially via the cAMP signaling system, but direct links are missing.

Purpose of the Study:

• To investigate the role of the cAMP effector, protein kinase A (PKA), in regulating angiogenic sprouting.
• To elucidate the molecular mechanisms by which PKA influences endothelial cell invasive capacity and matrix degradation.

Main Methods:

• Silencing or inhibiting PKA in human endothelial cells (ECs).
• Assessing EC invasive capacity, podosome rosette formation, and collagen matrix degradation.
• Investigating the involvement of Src-family kinases and cdc42.
• Measuring cell-based cdc42 activity and its interaction with RhoGDIα.

Main Results:

• PKA constitutively reduces EC angiogenic sprouting capacity in vitro and ex vivo.
• PKA inhibition increases EC invasive capacity, podosome formation, and collagen degradation.
• PKA activation inhibits EC cdc42 activity, partly by promoting its interaction with RhoGDIα.

Conclusions:

• PKA acts cell-autonomously to suppress angiogenic sprouting by inhibiting cdc42 activity.
• This pathway represents a novel regulatory mechanism for angiogenesis with implications for diseases.
• Targeting the PKA-cdc42 axis could offer therapeutic strategies for angiogenesis-dependent conditions.